FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385880913> ?p ?o ?g. }

• W4385880913 endingPage "e007114" @default.
• W4385880913 startingPage "e007114" @default.
• W4385880913 abstract "CD8+ T cells are a highly diverse population of cells with distinct phenotypic functions that can influence immunotherapy outcomes. Further insights on the roles of CD8+ specificities and TCR avidity of naturally arising tumor-specific T cells, where both high and low avidity T cells recognizing the same peptide-major histocompatibility complex (pMHC) coexist in the same tumor, are crucial for understanding T cell exhaustion and resistance to PD-1 immunotherapy.CT26 models were treated with anti-PD-1 on days 3, 6 and 9 following subcutaneous tumor implantation generating variable responses during early tumor development. Tetramer staining was performed to determine the frequency and avidity of CD8+ T cells targeting the tumor-specific epitope GSW11 and confirmed with tetramer competition assays. Functional characterization of high and low avidity GSW11-specific CD8+ T cells was conducted using flow cytometry and bulk RNA-seq. In vitro cytotoxicity assays and in vivo adoptive transfer experiments were performed to determine the cytotoxicity of high and low avidity populations.Treatment success with anti-PD-1 was associated with the preferential expansion of low avidity (Tetlo) GSW11-specific CD8+ T cells with Vβ TCR expressing clonotypes. High avidity T cells (Tethi), if present, were only found in progressing PD-1 refractory tumors. Tetlo demonstrated precursor exhausted or progenitor T cell phenotypes marked by higher expression of Tcf-1 and T-bet, and lower expression of the exhaustion markers CD39, PD-1 and Eomes compared with Tethi, whereas Tethi cells were terminally exhausted. Transcriptomics analyses showed pathways related to TCR signaling, cytotoxicity and oxidative phosphorylation were significantly enriched in Tetlo found in both regressing and progressing tumors compared with Tethi, whereas genes related to DNA damage, apoptosis and autophagy were downregulated. In vitro studies showed that Tetlo exhibits higher cytotoxicity than Tethi. Adoptive transfer of Tetlo showed more effective tumor control than Tethi, and curative responses were achieved when Tetlo was combined with two doses of anti-PD-1.Targeting subdominant T cell responses with lower avidity against pMHC affinity neoepitopes showed potential for improving PD-1 immunotherapy. Future interventions may consider expanding low avidity populations via vaccination or adoptive transfer." @default.
• W4385880913 created "2023-08-17" @default.
• W4385880913 creator A5014420290 @default.
• W4385880913 creator A5034314568 @default.
• W4385880913 creator A5036989846 @default.
• W4385880913 creator A5039296662 @default.
• W4385880913 creator A5050218469 @default.
• W4385880913 creator A5053869245 @default.
• W4385880913 creator A5062890490 @default.
• W4385880913 creator A5063880747 @default.
• W4385880913 date "2023-08-01" @default.
• W4385880913 modified "2023-09-26" @default.
• W4385880913 title "Reactivation of low avidity tumor-specific CD8⁺T cells associates with immunotherapeutic efficacy of anti-PD-1" @default.
• W4385880913 cites W1479760379 @default.
• W4385880913 cites W1643293176 @default.
• W4385880913 cites W1806981800 @default.
• W4385880913 cites W1940241680 @default.
• W4385880913 cites W1977967617 @default.
• W4385880913 cites W1986099961 @default.
• W4385880913 cites W1993956311 @default.
• W4385880913 cites W1996145004 @default.
• W4385880913 cites W2012267998 @default.
• W4385880913 cites W2016789384 @default.
• W4385880913 cites W2019719404 @default.
• W4385880913 cites W2021028235 @default.
• W4385880913 cites W2023352956 @default.
• W4385880913 cites W2049069390 @default.
• W4385880913 cites W2051893458 @default.
• W4385880913 cites W2058715880 @default.
• W4385880913 cites W2065924876 @default.
• W4385880913 cites W2066671159 @default.
• W4385880913 cites W2068767807 @default.
• W4385880913 cites W2085213267 @default.
• W4385880913 cites W2087276880 @default.
• W4385880913 cites W2097009175 @default.
• W4385880913 cites W2097353137 @default.
• W4385880913 cites W2105365352 @default.
• W4385880913 cites W2110485236 @default.
• W4385880913 cites W2123292645 @default.
• W4385880913 cites W2125679461 @default.
• W4385880913 cites W2158514188 @default.
• W4385880913 cites W2162457545 @default.
• W4385880913 cites W2412769274 @default.
• W4385880913 cites W2499609130 @default.
• W4385880913 cites W2513922839 @default.
• W4385880913 cites W2514996992 @default.
• W4385880913 cites W2527382084 @default.
• W4385880913 cites W2560367415 @default.
• W4385880913 cites W2587048937 @default.
• W4385880913 cites W2597802455 @default.
• W4385880913 cites W2599366563 @default.
• W4385880913 cites W2789563811 @default.
• W4385880913 cites W2791483720 @default.
• W4385880913 cites W2801022696 @default.
• W4385880913 cites W2899145148 @default.
• W4385880913 cites W2908581980 @default.
• W4385880913 cites W2909486828 @default.
• W4385880913 cites W2910699976 @default.
• W4385880913 cites W2913383852 @default.
• W4385880913 cites W2913558101 @default.
• W4385880913 cites W2924300946 @default.
• W4385880913 cites W2978325001 @default.
• W4385880913 cites W2997142001 @default.
• W4385880913 cites W3005326482 @default.
• W4385880913 cites W3023674145 @default.
• W4385880913 cites W3043035828 @default.
• W4385880913 cites W3045127673 @default.
• W4385880913 cites W3047018993 @default.
• W4385880913 cites W3080330000 @default.
• W4385880913 cites W3109198953 @default.
• W4385880913 cites W3180432427 @default.
• W4385880913 cites W3184584468 @default.
• W4385880913 cites W3189614948 @default.
• W4385880913 cites W3195857930 @default.
• W4385880913 cites W3201015884 @default.
• W4385880913 cites W3203166965 @default.
• W4385880913 cites W4214541685 @default.
• W4385880913 cites W4221089630 @default.
• W4385880913 cites W4296816736 @default.
• W4385880913 cites W4312095486 @default.
• W4385880913 doi "https://doi.org/10.1136/jitc-2023-007114" @default.
• W4385880913 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37586767" @default.
• W4385880913 hasPublicationYear "2023" @default.
• W4385880913 type Work @default.
• W4385880913 citedByCount "0" @default.
• W4385880913 crossrefType "journal-article" @default.
• W4385880913 hasAuthorship W4385880913A5014420290 @default.
• W4385880913 hasAuthorship W4385880913A5034314568 @default.
• W4385880913 hasAuthorship W4385880913A5036989846 @default.
• W4385880913 hasAuthorship W4385880913A5039296662 @default.
• W4385880913 hasAuthorship W4385880913A5050218469 @default.
• W4385880913 hasAuthorship W4385880913A5053869245 @default.
• W4385880913 hasAuthorship W4385880913A5062890490 @default.
• W4385880913 hasAuthorship W4385880913A5063880747 @default.
• W4385880913 hasBestOaLocation W43858809131 @default.
• W4385880913 hasConcept C129374314 @default.
• W4385880913 hasConcept C147483822 @default.
• W4385880913 hasConcept C153911025 @default.

• next